Morgan begins his tenure as executive vice president of finance on October 28 before formally stepping into the CFO position on November 19. He replaces Melissa Rasmussen, who concludes her term but will continue serving in an advisory capacity through the end of the calendar year to ensure a smooth transition.

Company filings indicate that Rasmussen's departure is unrelated to any internal disagreements. During her final year, she recorded total compensation of $2.6 million. Morgan brings extensive experience from his tenure at Indicor and his ten-year stint at Labcorp, where he managed finances for the firm's diagnostics and biopharma lab services divisions.